Japan Lung Cancer Market: By Treatment (Therapy and Diagnosis), Cancer Type (Small Cell Lung Cancer, Non-small Cell Lung Cancer and Lung Carcinoid Tumor), End User (Hospitals & Specialty Center, Diagnostic Laboratories and Others)—Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2024–2032
Japan lung cancer market is witnessing significant growth, with revenues expected to increase from approximately US$ 3,328.02 million in 2023 to US$ 9,376.83 million by 2032 at a CAGR of 12.46% during the forecast period 2024-2032. Read More
We Are Trusted By These Great Companies!
Published On: 28-Oct-2024 | Format: | Report ID: AA1024958